<DOC>
	<DOCNO>NCT00296790</DOCNO>
	<brief_summary>A comparison Zolpidem Tartrate Extended-Release ( Ambien CR ) v . Placebo Treatment Insomnia Associated Generalized Anxiety Disorder ( GAD ) Used Concomitantly Escitalopram ( Lexapro - antidepressant ) .</brief_summary>
	<brief_title>Ambien CR v . Placebo For Treatment Of Insomnia Associated With Anxiety When Used Concomitantly With Escitalopram ( Lexapro )</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Zolpidem</mesh_term>
	<criteria>INCLUSION CRITERIA : 1 . Male female age 21and 64 year , inclusive ; 2 . Women must use medically acceptable form contraception entire study period , : surgically sterilize , postmenopausal , agree use doublebarrier contraception throughout study period , must negative urine pregnancy test prior randomization ; 3 . Must meet diagnostic requirement Generalized Anxiety Disorder define Diagnostic Statistical Manual Mental Disorders ; 4 . Score least 18 Hamilton Rating Scale Anxiety ( HAMA ) 5 . Must either newly diagnose show symptom relapse period drug therapy anxiety . 6 . Subject must experience sleep disturbance least three night per week , least one month prior study entry , base historical data . 7 . Subject must stabilize longterm medication therapy least one month prior study entry . EXCLUSION 1 . History PostTraumatic Stress Disorder ; 2 . Concomitant Major Depressive Disorder Bipolar Disorder ; 3 . Any abnormal prestudy laboratory value require clinical intervention 4 . Shift work requirement regular change sleep schedule least six hour within previous month . 5 . Pregnant breastfeed 6 . History drug addiction , alcoholism , drug abuse 7 . Currently use benzodiazepine SSRI 2 day use within 28 day precede randomization . 8 . A positive urine drug screen compound would interfere assessment hypnotic . 9 . Use prescription nonprescription sedative drug ; 10 . Prior failure respond escitalopram therapy anxiety 11 . The presence untreated uncompensated clinically significant renal , endocrine , gastrointestinal , hepatic , respiratory , cardiovascular , neurologic , hematologic , oncologic , immunologic , cerebrovascular disease malignancy . 12 . History sleep apnea 13 . History myasthenia gravis 14 . Known hypersensitivity and/or allergy previous adverse experience zolpidem escitalopram excipients 15 . Subject currently participate another clinical trial ( within 28 day screen ) .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 2007</verification_date>
</DOC>